Related to Medicago and Genopole to Set Up Plant in France for Influenza Vaccine Production

• GSK and EDB Pledge $35M to Augment Green Manufacturing in Singapore
  
• Emergent Wins $107M Contract to Triple Anthrax Vaccine Production
  
• Cytos and Life Technologies Partner with A*Star in Separate Deals
  
• PPD Expands cGMP Lab Services in North America
  
• NIH Bankrolls Six Centers with $100M to Characterize Human Immune Responses
  
• Emergent BioSolutions and TLV Set Up Influenza-Focused JV
  
• Lonza Acquires Vivante to Expand into Viral-Based GMP Manufacturing
  
• Lonza Provides GSK with Manufacturing Capacity for Five Clinical-Stage mAbs
  
• J&J and Crucell in Advanced Negotiations for €1.75B Acquisition Deal
  
• GSK Obtains Rights to Delphi’s Antibiotic-Free Tech for Recombinant Vaccines
  
• SAFC Adds 50,000 Square Feet to Jerusalem Site to Bump Up Fermentation Capabilities
  
• GenVec Receives Second-Year Funding from SAIC for HIV and Flu Vaccine Development
  
• Novartis Teams with Synthetic Genomics Vaccines to Develop Flu Seed Virus Banks
  
• Pivotal Study Finds Novartis Adjuvanted Flu Vaccine 89% Effective in Infants and Children
  
• Sinovac Wins $1.8M Chinese Flu Vaccine Contract and Gets Anflu Sanctioned in Hong Kong
  
• Japan Approves BioCryst/Shionogi Intravenous Flu Vaccine for Use in Infants and Children
  
• Protein Sciences Expands Flu Vaccine Candidate License Arrangement with UMN
  
• Takeda Snags Exclusive License to Baxter’s Vero Cell Culture Tech for Flu Vaccine
  
• Medicago and IDRI Use DARPA Grant for Avian Flu Vaccine Development
  
• Genzyme to Build €250M Myozyme/Lumizyme Production Plant in Belgium